Magic mine / shutterstock.com
Nevro, a US-based medical device company, filed a complaint against Boston Scientific yesterday in a US district court for allegedly infringing patents covering Nevro’s spinal cord stimulation (SCS) therapy.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
patent, SCS, FDA, Nevro, Boston Scientific, spinal cord stimulation